Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
1.460
-0.090 (-5.81%)
Mar 31, 2025, 1:25 PM EDT - Market open
Scienture Holdings Employees
As of December 31, 2023, Scienture Holdings had 19 total employees, including 14 full-time and 5 part-time employees.
Employees
19
Change
n/a
Growth
n/a
Revenue / Employee
$7,192
Profits / Employee
$477,147
Market Cap
18.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 19 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SCNX News
- 6 days ago - SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization - GlobeNewsWire
- 12 days ago - Scienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days - GlobeNewsWire
- 13 days ago - SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $1.5 billion in sales in 2024. - GlobeNewsWire
- 25 days ago - SCIENTURE to commercially launch REZENOPY®, a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P. - GlobeNewsWire
- 2 months ago - Scienture Holdings, Inc. Announces Dr. Narasimhan Mani's Participation in the 8th Annual Conference of The Society for the Study of Xenobiotics - GlobeNewsWire
- 3 months ago - Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025 - GlobeNewsWire
- 3 months ago - Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041 - GlobeNewsWire
- 6 months ago - TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX” - GlobeNewsWire